Company Overview - Pluri Inc is a leading biotechnology company that transforms cells into solutions promoting global wellbeing and sustainability [1] - The company operates in regenerative medicine, foodtech, and agtech, and offers CDMO services [7] - Pluri's proprietary 3D cell expansion technology is patented, scalable, cost-effective, and consistent [7] Strategic Collaboration - Pluri has entered a proof of concept agreement with a leading international agriculture corporation to boost global vegetable supply, streamline supply chains, and combat climate change [1] - The collaboration leverages Pluri's expertise in cell-expansion technologies and cellular agriculture, combined with the partner's global presence and knowledge of the food industry [10] - The partnership aims to minimize environmental impact, foster food security, and build sustainable, high-quality agricultural solutions [5] Market Context - The global vegetable farming market is valued at 1.6 trillion by 2029, with a CAGR of 3.4% from 2024 to 2029 [6] - The global population is projected to increase from 7.5 billion to 8.6 billion by 2030 and 11.2 billion by the end of the century, driving the need for alternative agricultural technologies [2] Business Strategy - Pluri's strategy involves collaborating with leading global companies across industries to generate revenue through innovative projects [2] - The company believes this collaboration has the potential to positively impact the vegetable market and create significant shareholder value [2] Technology and Innovation - Pluri's 3D cell expansion technology is expected to benefit farmers worldwide by enabling sustainable, high-quality agricultural solutions [5] - The company is pioneering a biotech revolution to address challenges in medicine, climate change, food scarcity, and animal cruelty [7]
Pluri Announces €1 Million Proof of Concept Agreement to Enhance Global Sustainable Vegetable Supply